Vanomycin tablet
Reading File
Vancomycin is a glycopeptide antibiotic used primarily for serious Gram-positive infections. Importantly, it is not available as an oral tablet for systemic use - it is given IV for systemic infections. Oral vancomycin capsules/solution exist only for gut-limited infections (C. difficile colitis) because oral vancomycin is not absorbed systemically.
Searching sources...
Finding Sources
Searching the Web
vancomycin oral tablet formulation uses dosage
Reading File
Reading File
Reading File
Here is a comprehensive overview of Vancomycin (commonly misspelled "Vanomycin"):
Vancomycin - Complete Drug Profile
What It Is
Vancomycin is a glycopeptide antibiotic produced by Streptomyces orientalis. It inhibits early stages of cell wall peptidoglycan synthesis, making it bactericidal against most Gram-positive organisms.
Spectrum of Activity (Gram-positive organisms only)
- Staphylococcus aureus including MRSA and coagulase-negative staphylococci
- Streptococcus species including S. pneumoniae
- Enterococcus species
- Bacillus, Corynebacterium jeikeium
- Gram-positive anaerobes: Peptostreptococcus, Actinomyces, Clostridium, Propionibacterium
- NOT active against Gram-negative organisms
(Harrison's Principles of Internal Medicine 22E)
Formulations - KEY POINT
| Formulation | Route | Purpose |
|---|---|---|
| IV solution | Intravenous | Systemic infections (MRSA sepsis, endocarditis, pneumonia, osteomyelitis) |
| Oral capsules / solution | Oral (PO) | C. difficile infection & S. aureus enterocolitis ONLY |
There is no vancomycin "tablet." The oral form comes as capsules (Vancocin) or the IV powder dissolved in water/juice. Oral vancomycin is poorly absorbed from the gut - this is actually why it works for C. difficile: it stays in the colon at very high concentrations without causing systemic toxicity.
Clinical Uses
IV Vancomycin (systemic):
- MRSA infections: bacteremia, endocarditis, pneumonia, osteomyelitis, skin/soft tissue infections
- Alternative for MSSA when patient cannot tolerate beta-lactams
- Empiric coverage in suspected Gram-positive sepsis
- CNS shunt infections
Oral Vancomycin (gut-limited):
- First-line treatment for Clostridioides difficile infection (CDI)
- Standard dose: 125 mg every 6 hours x 10 days (as effective as 500 mg QID)
- Severe/fulminant CDI: 500 mg QID
- Staphylococcus aureus enterocolitis
(Sleisenger & Fordtran's GI and Liver Disease; Jawetz Medical Microbiology 28E)
Note: IV vancomycin does NOT work for CDI - effective colonic concentrations are not achieved parenterally.
Pharmacokinetics
- Oral: Poorly/not absorbed systemically - stays in gut lumen (ideal for CDI)
- IV: Widely distributed in tissues; excreted renally - requires dose adjustment in renal impairment
- PK/PD target: AUC/MIC ratio >400 is the best predictor of efficacy (concentration-dependent killing)
- Trough target for MRSA: 15-20 mcg/mL
Adverse Effects
| Effect | Details |
|---|---|
| Nephrotoxicity | Most important; risk increases with trough >20 mcg/mL; worsened by aminoglycosides |
| Red Man Syndrome (Vancomycin Infusion Reaction) | Histamine-mediated erythematous rash on face/neck/trunk from rapid infusion; treat with diphenhydramine + slow infusion |
| Ototoxicity | Rare with modern purified formulations; was more common historically |
| Thrombophlebitis | At IV site |
| Leukopenia | Uncommon |
(Harrison's 22E; Jawetz Medical Microbiology 28E)
Resistance Concerns
- VISA (Vancomycin-Intermediate S. aureus): MIC 4-8 mcg/mL
- VRSA (Vancomycin-Resistant S. aureus): via acquisition of vanA genes from VRE
- VRE (Vancomycin-Resistant Enterococci): major problem; VanA type also resistant to teicoplanin; VanB type remains susceptible to teicoplanin
- For enterococcal sepsis/endocarditis, vancomycin must be combined with an aminoglycoside
Monitoring
- Renal function (serum creatinine) regularly
- Vancomycin serum levels (trough or AUC monitoring)
- Auditory function if prolonged use
Important Practical Note
The IV powder for injection can be dissolved in water and given orally for CDI at a much lower cost than branded Vancocin capsules - this is a commonly used cost-saving strategy in clinical practice. (Sleisenger & Fordtran)
This is a shared conversation. Sign in to Orris to start your own chat.